Consistently, the administration of ERK2 inhibitor was able to rescue motor deficits and was able to reduce the levels of abnormally phosphorylated Tau in mouse model of tauopathy (Le Corre et al., 2006; Hanger et al., 2009). The gene discussed is MAPK1; the disease is tauopathy.